RENÉE AGUIAR LUCANDER — CEO

Get alerts when RENÉE AGUIAR LUCANDER trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Hansa Biopharma AB.

12-month summary

Net buyer over the last 12 months

1 open-market buy, 0 sales, 0 share awards · SEK 1,503,060.00 bought, SEK 0.00 sold

Roles

Hansa Biopharma AB Stockholm
CEO
24.07.2025 – 25.09.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
25.09.2026Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
47,000SEK 31.98
SEK 1,503,060.00
↗
28.07.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
50,000SEK 27.40
SEK 1,370,000.00
↗
27.07.2025Hansa Biopharma AB Stockholm
Other / unclassified
1,652,500SEK 10.89
SEK 17,995,725.00
↗
24.07.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
100,000SEK 27.00
SEK 2,700,000.00
↗